Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Agency, alternative, answer, answered, arisen, ASU, award, Bank, beginning, bifurcation, Binomial, CEO, CFO, chose, closure, compensatory, Concurrent, constitute, corroborated, coverage, decided, deducting, demand, denying, derecognition, disability, discontinued, display, disrupted, dividend, duration, electronic, eligible, embedded, Emerging, entry, equivalent, ErgoFlex, European, FDA, Force, foregoing, fractional, gain, good, governmental, Gregory, hand, handled, harm, hierarchy, host, intrinsic, joint, longer, lump, magnitude, maker, mandatorily, memorializing, merit, milestone, minimize, modified, occurred, ordinary, outbreak, pandemic, party, past, predict, premium, prepaid, prop, provision, recurring, remotely, rendered, requisite, Restated, restatement, retroactively, retrospective, reverse, rounded, scheduled, segment, shareholder, Sheffield, single, space, spending, split, spread, submission, Subtopic, sum, supported, supporting, Task, team, transfer, Translational, underwriting, Union, unissued, unreimbursed, unsecured, unvested, vacation, Ventura, vigorously, volatility, wholly, withholding, world, worldwide, yield
Removed:
accrual, accrue, achievement, acquired, acquisition, annually, apparent, area, asset, book, CA, capitalized, compound, conform, consent, consequential, consistently, consisting, contemplated, continuing, conveyed, culmination, customary, Cytovance, decreased, deemed, defense, defer, Deposit, depreciated, Depreciation, developing, directly, discounted, diversity, dividing, economic, Efficient, element, Empery, employee, enacted, equipment, estate, evaluate, evident, executory, existing, experience, expertise, expression, favorable, filing, Fixed, flow, found, generation, geographic, GMP, goodwill, group, growth, Hepalink, highly, idea, impaired, impairment, incorporate, indefinite, indemnification, independent, indirectly, inherent, institutional, insured, intangible, integrity, investor, involvement, Keystone, leasehold, licensed, licensee, liquid, lived, lower, LP, machinery, maintenance, making, marketable, Master, measurement, methodology, microbial, monitored, negative, objectivity, offer, original, origination, patent, patentable, patented, performed, periodically, plant, positive, preparing, prepay, production, projected, pursuing, readily, real, realized, receivable, recombinant, recoverable, registration, relate, relief, rent, response, reviewed, secured, security, selection, senior, separate, shorter, statutory, Steven, substantive, table, technological, testing, thousand, timing, twenty, typically, undiscounted, utility, utilizing, variable, viable, weighted, Weldon
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Amended and Restated Employment Agreement with Anthony Cataldo, Dated April 23, 2021
- 10.2 Amended and Restated Employment Agreement with Michael Handelman, Dated April 23, 2021
- 10.3 Amended and Restated Employment Agreement with DR. Gregory Berk, Dated April 23, 2021
- 31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32.1 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32.2 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
GTBP similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, I, Michael Handelman, Chief Financial Officer and Principal Accounting Officer of GT Biopharma, Inc. (the “Company”), hereby certify that, to the best of my knowledge:
(i) the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March 31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
Date: May 17, 2021 | By: | /s/ Michael Handelman | |
Name: Michael Handelman | |||
Title: Chief Financial Officer and Principal Accounting Officer |